Black Diamond Therapeutics BDTX
NASDAQ BDTX
$2.08 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Black Diamond Therapeutics (BDTX) Cash & Equivalents (2018 - 2026)

Updated

Black Diamond Therapeutics (BDTX) reported Cash & Equivalents of $19.19 million for Q2 2026, down 36.0% from $29.99 million a year earlier and down 36.2% from the prior quarter.

Analysis

Black Diamond Therapeutics (BDTX) Cash & Equivalents (2018 - 2026) Analysis & Trends

At the end of FY2025, Black Diamond Therapeutics posted Cash & Equivalents of $20.99 million, down 42.4% from FY2024.

  • Cash & Equivalents has a five-year compound annual growth rate of -9.5% (FY2020 to FY2025).
  • By year, Cash & Equivalents came in at $36.44 million in FY2024 (-35.2%), $56.22 million in FY2023 (+63.8%), $34.32 million in FY2022 (-47.8%) and $65.8 million in FY2021 (+90.1%).
  • The Q2 2026 figure ranks as the lowest quarterly Cash & Equivalents since Q1 2021.
  • Year over year, Cash & Equivalents has now declined in each of the last three quarters, with growth averaging 8.5% over the last eight quarters.
  • The high point for year-over-year Cash & Equivalents in five years was Q1 2025 (growth of 287.2%); the low point was Q1 2026 (a decline of 69.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $30.07 million (Q1 2026), $20.99 million (Q4 2025) and $30.86 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 16.91 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 6.57 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 4.90 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 976.00 Mn
10 Black Diamond Therapeutics 119.32 Mn -373.60 Mn - 19.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.19 Mn
Mar 31, 2026 30.07 Mn
Dec 31, 2025 20.99 Mn
Sep 30, 2025 30.86 Mn
Jun 30, 2025 29.99 Mn
Mar 31, 2025 98.42 Mn
Dec 31, 2024 36.44 Mn
Sep 30, 2024 23.43 Mn
Jun 30, 2024 32.81 Mn
Mar 31, 2024 25.42 Mn
Dec 31, 2023 56.22 Mn
Sep 30, 2023 57.98 Mn
Jun 30, 2023 41.89 Mn
Mar 31, 2023 39.14 Mn
Dec 31, 2022 34.32 Mn
Sep 30, 2022 53.96 Mn
Jun 30, 2022 55.88 Mn
Mar 31, 2022 54.08 Mn
Dec 31, 2021 65.80 Mn
Sep 30, 2021 46.60 Mn
API Access

Black Diamond Therapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BDTX&period=max&api_key=YOUR_API_KEY